Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07102147 · ClinicalTrials.gov registry record · NA

Telehealth Collaborative Care Model (CoCM) in Lung Cancer

A NA study of Anxiety and Lung Cancer (Diagnosis), sponsored by Abramson Cancer Center at Penn Medicine.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT07102147: Recruiting NA study of Anxiety and Lung Cancer (Diagnosis), sponsored by Abramson Cancer Center at Penn Medicine.

NCT07102147 is a NA study of Anxiety and Lung Cancer (Diagnosis) that is actively recruiting participants, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 30 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07102147, a NA study of Anxiety and Lung Cancer (Diagnosis), is actively recruiting participants, sponsored by Abramson Cancer Center at Penn Medicine.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The goal of this trial is to compare the impact of two outreach strategies (high touch vs. standard outreach) on a collaborative care program delivered via telehealth to patients with lung cancer.

Primary Outcome

The number of referred patients that complete the intake assessment divided by the total number of referred patients.

Interventions

  • BEHAVIORAL High Touch Outreach

Study Locations (1)

Pennsylvania

  • Abramson Cancer Center at the University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-08-18
Est. Completion 2027-02
Phase NA

What NCT07102147 shows while recruiting

NCT07102147 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (93% lower).

The record links to 3 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which High Touch Outreach is the first listed.

NCT07102147 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT07102147 about?

NCT07102147 is a clinical study titled "Telehealth Collaborative Care Model (CoCM) in Lung Cancer". The goal of this trial is to compare the impact of two outreach strategies (high touch vs. standard outreach) on a collaborative care program delivered via telehealth to patients with lung cancer.

What is the current status of trial NCT07102147?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-08-18. Estimated completion is 2027-02.

What conditions does trial NCT07102147 study?

This clinical trial studies the following conditions: Anxiety, Lung Cancer (Diagnosis), Depression in Adults.

What interventions are being tested in trial NCT07102147?

The interventions under investigation include: High Touch Outreach (BEHAVIORAL).

Who is sponsoring clinical trial NCT07102147?

This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07102147 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07102147's enrollment target sits among peer trials

30 300th of 364 higher than 55 of 364 other Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07102147, the US trial registry maintained by the National Library of Medicine. NCT07102147 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.